Ahmed Massoud

Dr. Ahmed Massoud

Field of Advanced Basic Sciences, AlAlamein International University, El Alamein, Egypt
orcid
Aspiring educator, researcher, and bio-scientific designer w...

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2026 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
MZMohammed Zayed
Mohammed Zayed
Ahmed MassoudAhmed Massoud
Ahmed Massoud
EEEnas Elwakeel
Enas Elwakeel
PEPrehan Ezzat
Prehan Ezzat
YAYaser Alammar
Yaser Alammar
Byung-Hoon JeongByung-Hoon Jeong
Byung-Hoon Jeong

25 October 2025 in Current Obesity Reports
Verified
Journal Article
Closed access
PDF file
MZMohammed Zayed
Mohammed Zayed
Ahmed MassoudAhmed Massoud
Ahmed Massoud
FHFatma Hassan
Fatma Hassan
EEEnas Elwakeel
Enas Elwakeel
YMYusuf Mahmoud
Yusuf Mahmoud
Byung-Hoon JeongByung-Hoon Jeong
Byung-Hoon Jeong

9 April 2026 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
MZMohammed Zayed
Mohammed Zayed
Ahmed MassoudAhmed Massoud
Ahmed Massoud
RARoya Al-Haddad
Roya Al-Haddad
AAAhmed Al-Kubaisi
Ahmed Al-Kubaisi
WSWalid Said
Walid Said
Byung-Hoon JeongByung-Hoon Jeong
Byung-Hoon Jeong

27 May 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
Ahmed MassoudAhmed Massoud
Ahmed Massoud
AEAmina E. Essawy
Amina E. Essawy
MAMohammed Alfredan
Mohammed Alfredan
AAAshraf Abdel-Moneim
Ashraf Abdel-Moneim
RGRehab A. Gomaa
Rehab A. Gomaa
SSSherine Abdel Salam
Sherine Abdel Salam
Background/Objectives: Betanin (BET), a prominent phytochemical mainly derived from Beta vulgaris, exhibits strong anti-inflammatory and antioxidant activities owing to its distinctive chemical structure. Nevertheless, its potential analgesic effect in the context of inflammatory pain remains insufficiently explored. Accordingly, this study investigated the analgesic effects of BET in a complete Freund’s adjuvant (CFA)-induced rat model of inflammatory pain. Methods: Rats received a single subcutaneous injection of 100 µL CFA to induce inflammatory pain, followed by oral administration of BET at doses of 40 or 80 mg/kg/day for 14 days. Results: BET treatment significantly reduced paw edema and improved HPL (hot plate latency) in CFA-injected rats. Biochemically, in the ipsilateral spinal cord of rats, BET at both 40 and 80 mg/kg significantly increased IL-4, and only the 80 mg/kg dose significantly reduced oxidative stress (MDA) and IL-1β. TNF-α levels were slightly reduced at both doses and did not reach statistical significance versus CFA. At the molecular level, miR-107 was significantly downregulated by BET at 80 mg/kg (but not 40 mg/kg), while miR-145 was significantly upregulated by both 40 mg/kg and 80 mg/kg compared to CFA. Pearson’s correlation indicated that miR-107 was positively correlated with MDA, IL-1β and TNF-α but negatively with IL-4, whereas miR-145 was positively correlated with IL-4 but negatively with IL-1β. PCA biplot analysis corroborated these findings, showing simultaneous presence of MDA, IL-1β, TNF-α, and miR-107 with CFA, and IL-4 and miR-145 were only related to control and CFA+BET80 groups. In addition, using transmission electron microscopy imaging, we found that BET alleviated neuronal damage in CFA-treated rats. Furthermore, molecular docking analysis predicted that BET may exhibit stable binding interactions with several inflammation- and apoptosis-related targets, including AKT1, mTOR, IKKβ, TNF-α, IL-1β, COX-2, caspase-3, caspase-7, and caspase-8, supporting its multi-target anti-inflammatory and antiapoptotic effects. Conclusions: Overall, our data suggest that BET can possibly exert analgesic effects in CFA-induced inflammatory pain by modulating oxidative stress and favoring a shift toward an anti-inflammatory status. These effects coincided with downregulation of miR-107, overexpression of miR-145, and improvements in inflammatory pain behaviors. Further investigations are required to validate the involvement of specific miRNA- and pathway-mediated effects. Nevertheless, our findings highlight BET as a promising natural candidate for future development of anti-inflammatory and analgesic strategies.

1 January 2026 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MZMohammed Zayed
Mohammed Zayed
MMMaha Mahmoud
Maha Mahmoud
Ahmed MassoudAhmed Massoud
Ahmed Massoud
RDRenad Darwish
Renad Darwish
Byung-Hoon JeongByung-Hoon Jeong
Byung-Hoon Jeong

8 September 2026 in Tissue and Cell
Verified
Journal Article
Closed access
AEAmina E. Essawy
Amina E. Essawy
RFRania I. Fahmy
Rania I. Fahmy
RGRehab A. Gomaa
Rehab A. Gomaa
HFH.A. Fetouh
H.A. Fetouh
MHMohamed Helal
Mohamed Helal
WAWessam Mohamad Abdel-Wahab
Wessam Mohamad Abdel-Wahab